Bizarre Patents
A new toilet tank assembly aquarium for housing aquatic creatures.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7351723 | Freeze-dried pantoprazole preparation and pantoprazole injection Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have adv... | 04/01/2008 |
| 6855347 | Composition for treating gastric ulcer and a process for preparing the same The present invention relates to a novel synergistic herbal composition for the treatment of gastric ulcer, a method for preparing said synergistic herbal composition and a process for the treatment of gastric ulcer using said composition and more particularly, the ... | 02/15/2005 |
| 6780881 | Freeze-dried pantoprazole preparation and pantoprazole injection Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have adv... | 08/24/2004 |
| 6767559 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present invention admixe... | 07/27/2004 |
| 6696486 | Medical use for atypical ଲ-adrenoceptor agonists The present invention relates to the use of compounds which act as agonists at atypical beta-adrenoceptors, for the treatment of gastrointestinal disorders, especially peptic ulceration, oesophagitis, gastritis and duodenitis, intestinal ulcerations, incl... | 02/24/2004 |
| 6593339 | Use of compounds as antibacterial agents The present invention discloses a new use of NO-releasing NSAIDs, especially NO-releasing NSAIDs of the formula I, or a pharmaceutically acceptable salt or enantiomer thereof, for the manufacture of a medicament for the treatment of bacterial infections, ... | 07/15/2003 |
| 6555534 | Method and compositions for the control or eradication of Helicobacter pylori The use of 4,4-methylenebis (tetrahydro-1,2-4-thiadiazine-1,1 -dioxide) in the eradication and control of the microorganism Helicobacter pylori in humans is disclosed.... | 04/29/2003 |
| 6518250 | Agent for preventing and curing hindrance of ischemic reperfusion An agent for preventing and curing the hindrance of ischemic reperfusiton is disclosed which has as an active component thereof a chromanol glycoside represented by the following general formula: ##STR1## [wherein R1, R2, R3 | 02/11/2003 |
| 6515008 | Formulation The present invention is directed to a novel pharmaceutical composition of polymorph B which has been found to be stable and palatable for long term commercial usage.... | 02/04/2003 |
| 6498171 | Hydroxyomeprazole compositions Methods and compositions are disclosed utilizing hydroxyomeprazole for the treatment of ulcers in humans. Hydroxyomeprazole exhibits a lessened liability toward drug-drug interactions than omeprazole and a more predictable dosing regimen than omeprazole. ... | 12/24/2002 |
| 6489317 | Method for eradication of Helicobacter pylori The invention provides methods for the treatment and/or prevention of recurrence of a gastrointestinal disorder associated with Helicobacter pylori in a patient requiring said treatment and/or prevention, which comprise administering to the patient a ther... | 12/03/2002 |
| 6471955 | Ph-selective delivery system using crosslinked polymeric resins as vehicles This invention provides a method of preparing a polymeric delivery system for active ingredients having enhanced site specific release performance characteristics. The delivery system is formed either by attaching the active ingredient to a linker through... | 10/29/2002 |
| 6468964 | Control of acidic gut syndrome According to the present invention there is provided a method for the treatment or prophylaxis of acidic gut syndrome resulting from the accumulation of acid and production of endotoxin in the gastrointestinal tract of a human or an animal, said accumulat... | 10/22/2002 |
| 6444232 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 09/03/2002 |
| 6420435 | Method for treating gastrointestinal disorders Methods of treating gastrointestinal disorders (e.g. heart bum, GERD, and gastric indigestion) comprising orally administering therapeutically effective amounts of limonene are described herein.... | 07/16/2002 |
| 6379651 | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases The invention relates to concomitant treatment with bismuth compounds, other antibacterial compounds, and/or antibiotics in oral-topical and peroral dosage forms to eradicate H. pylori from its niches both in the dental plaque and in the gastric mucosa in... | 04/30/2002 |
| 6365201 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 04/02/2002 |
| 6160017 | Preventives and remedies for ulcerous colitis and/or crohn's disease The invention relates to an agent for preventing and treating ulcerous colitis and/or Crohn's disease, comprising conagenin or a pharmaceutically acceptable salt thereof as an active ingredient. According to the present invention, there is provided an age... | 12/12/2000 |
| 6147053 | Combination containing growth factors and polyelectrolytes The invention relates to active substance combinations which consist of at least one polypeptide with the biological action of fibroblast growth factors and of at least one cationic polyelectrolyte. These combinations permit improved dosage of the FGF act... | 11/14/2000 |
| 6117868 | Treatment of gastrointestinal ulcers or gastritis caused by microbial infection A method and composition for the treatment of infectious gastrointestinal ulcer disease or infectious gastritis disease of microbially infected gastrointestinal tissue in a mammal involves administration of an antimicrobial amount of an antimicrobial medi... | 09/12/2000 |
| 6110891 | Lectin compositions and uses thereof This invention provides methods for: the control of mucosal cell proliferation; the reduction and/or treatment of damage caused by a cell-damaging agent; and for the reduction and/or treatment of a metabolic disorder. The methods comprise administering to... | 08/29/2000 |
| 6110506 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 08/29/2000 |
| 6086882 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 07/11/2000 |
| 6083509 | Phytodrug for management of peptic ulcer and methods of preparing and using same A phytochemical composition for management of peptic ulcer conditions in humans is provided. The composition is a hot water extract of powdered Indigofera arrecta plant leaves. The extract may be prepared by contacting the powdered leaves with hot water f... | 07/04/2000 |
| 6071953 | Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them Chromans of formula I ##STR1## with the meanings of R(A), R(B) and R(1) to R(8) stated in the specification are suitable for producing a medicament for blocking the K+ channel that is opened by cyclic adenosine monophosphate (cAMP); ... | 06/06/2000 |
| 6048552 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 04/11/2000 |
| 6043243 | Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug A pyrrolidine derivative or a salt thereof expressed by the following formula 1: ##STR1## wherein R1 is an alkenyl group; R2 is a lower alkoxy group or a halogen atom; R3 is a lower alkyl group; X is a group expressed... | 03/28/2000 |
| 6013680 | Digestive enzyme-containing medicament To provide a medicament that can be used as a drug for the effective treatment of gastric ulcers, duodenal ulcers and like diseases of the digestive tract. The medicament comprises a combination of at least one agent selected from the group consisting of ... | 01/11/2000 |
| 5968906 | Sucralfate preparations Sucralfate containing preparations which contain both an organic acid having at least two carboxyl groups or at least one carboxyl group in the molecule and sucralfate are described. The sucralfate containing preparations have enhanced sucralfate adhesion... | 10/19/1999 |
| 5935998 | Use of all allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection or associated diseases Use of compounds of formula (I), wherein R has various significances, in free base form or in pharmaceutically acceptable salt form, as agents against H. pylori infection and associated diseases.... | 08/10/1999 |
| 5914135 | Liquid antacid compositions Calcium carbonate liquid antacid compositions containing one or more pH adjusting agents to maintain the pH above 9.0, preferably above 9.5. The resultant antacid liquid possesses superior resistance to microbial attack and enhanced taste properties.... | 06/22/1999 |
| 5900413 | Treatment of H. pylori infections An infection with Helicobacter may successfully be treated with a compound of the formula ##STR1## wherein R1 is hydrogen or methyl and R2 is hydrogen or L-alanine-L-alanyl, and the pharmaceutically acceptable acid additive ... | 05/04/1999 |
| 5885960 | Method of treatment comprising administering a combination comprising FGF and polyelectrolytes The invention relates to active substance combinations which consist of at least one polypeptide with the biological action of fibroblast growth factors and of at least one cationic polyelectrolyte. These combinations permit improved dosage of the FGF act... | 03/23/1999 |
| 5871774 | Drug units and methods for use Medical materials for use in treating maladies in living beings, such as ulcers and other conditions of the digestive tract. In one form, a container is provided for a medication which container also contains an adhesive material which is operatively rele... | 02/16/1999 |
| 5858365 | Methods for the treatment of wounds using butyric acid salts and derivatives This invention is directed to methods of administering physiologically stable and safe compositions of butyric acid salts and derivatives to a patient for the purpose of wound healing.... | 01/12/1999 |
| 5852004 | Drug and pharmaceutical composition for the treatment of lesions of the digestive tract Use of at least one polymer or one biopolymer, called HBGFPPs, specifically protecting the growth factors of families of FGFs and beta TGFs from tryptic degradation and not significantly inhibiting coagulation, in the manufacture of a drug for the treatme... | 12/22/1998 |
| 5843482 | Products and processes for the treatment of the alimentary canal Complexes of bismuth, e.g. bismuth salts, and polyacrylate, e.g. carbomer, are discloses which may be incorporated into pharmaceutical compositions for oral, oral delayed-release, and rectal administration. The complexes may be combined with an antibiotic... | 12/01/1998 |
| 5837240 | Multimeric, recombinant urease vaccine Methods and compositions are provided for prophylactic and antibacterial therapy for Helicobacter, particularly for Helicobacter pylori, infection of humans. The immunogenic composition of the invention is composed of a plurality of multimeric complexes, ... | 11/17/1998 |
| 5750535 | Pharmaceutical agents for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria The present invention relates to a method treating or preventing disorders caused by a spiral urease-positive gram-negative bacterium such as Helicobacter pylori in mammals, including humans, using compounds that are substance P receptor antagonists and, ... | 05/12/1998 |
| 5728711 | Treatment of H. pylori infections An infection with Helicobacter may successfully be treated with a compound of the formula ##STR1## wherein R1 is hydrogen or methyl and R2 is hydrogen or L-alanine-L-alanyl, and the pharmaceutically acceptable acid additive ... | 03/17/1998 |
